Diffuse Large B-Cell Lymphoma von Sehn, Laurie H, Salles, Gilles

Volltext

Bispecific antibodies for the treatment of B-cell lymphoma: promises, unknowns, and opportunities von Falchi, Lorenzo, Vardhana, Santosha A., Salles, Gilles A.

Volltext

The 2016 revision of the World Health Organization classification of lymphoid neoplasms von Swerdlow, Steven H., Campo, Elias, Pileri, Stefano A., Harris, Nancy Lee, Stein, Harald, Siebert, Reiner, Advani, Ranjana, Ghielmini, Michele, Salles, Gilles A., Zelenetz, Andrew D., Jaffe, Elaine S.

Volltext

From genetics to the clinic: a translational perspective on follicular lymphoma von Huet, Sarah, Sujobert, Pierre, Salles, Gilles

Volltext

Prospects in the management of patients with follicular lymphoma beyond first-line therapy von Qualls, David, Salles, Gilles

Volltext

Spotlight on polatuzumab vedotin: new standards for diffuse large B-cell lymphoma? von Ghione, Paola, Salles, Gilles

Volltext

Mutational landscape of gray zone lymphoma von Sarkozy, Clémentine, Hung, Stacy S., Chavez, Elizabeth A., Duns, Gerben, Takata, Katsuyoshi, Chong, Lauren C., Aoki, Tomohiro, Jiang, Aixiang, Miyata-Takata, Tomoko, Telenius, Adèle, Slack, Graham W., Molina, Thierry Jo, Ben-Neriah, Susana, Farinha, Pedro, Dartigues, Peggy, Damotte, Diane, Mottok, Anja, Salles, Gilles A., Casasnovas, Rene-Olivier, Savage, Kerry J., Laurent, Camille, Scott, David W., Traverse-Glehen, Alexandra, Steidl, Christian

Volltext

A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma von Morschhauser, Franck, Feugier, Pierre, Flinn, Ian W., Gasiorowski, Robin, Greil, Richard, Illés, Árpád, Johnson, Nathalie A., Larouche, Jean-François, Lugtenburg, Pieternella J., Patti, Caterina, Salles, Gilles A., Trněný, Marek, de Vos, Sven, Mir, Farheen, Samineni, Divya, Kim, Su Y., Jiang, Yanwen, Punnoose, Elizabeth, Sinha, Arijit, Clark, Emma, Spielewoy, Nathalie, Humphrey, Kathryn, Bazeos, Alexandra, Zelenetz, Andrew D.

Volltext

Positron emission tomography-computed tomography before autologous stem cell transplant in follicular lymphoma: coming too late? von Sarkozy, Clémentine, Salles, Gilles

Volltext

Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials von Casulo, Carla, Dixon, Jesse G., Le-Rademacher, Jennifer, Hoster, Eva, Hochster, Howard S., Hiddemann, Wolfgang, Marcus, Robert, Kimby, Eva, Herold, Michael, Sebban, Catherine, Gyan, Emmanuel, Foon, Kenneth, Nielsen, Tina, Vitolo, Umberto, Salles, Gilles A., Shi, Qian, Flowers, Christopher R.

Volltext

Diffuse large B-cell lymphoma: new targets and novel therapies von Cheson, Bruce D., Nowakowski, Grzegorz, Salles, Gilles

Volltext

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma von Schuster, Stephen J, Bishop, Michael R, Tam, Constantine S, Waller, Edmund K, Borchmann, Peter, McGuirk, Joseph P, Jäger, Ulrich, Jaglowski, Samantha, Andreadis, Charalambos, Westin, Jason R, Fleury, Isabelle, Bachanova, Veronika, Foley, S. Ronan, Ho, P. Joy, Mielke, Stephan, Magenau, John M, Holte, Harald, Pantano, Serafino, Pacaud, Lida B, Awasthi, Rakesh, Chu, Jufen, Anak, Özlem, Salles, Gilles, Maziarz, Richard T

Volltext

The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee von Campo, Elias, Jaffe, Elaine S, Cook, James R, Quintanilla-Martinez, Leticia, Swerdlow, Steven H, Anderson, Kenneth C, Brousset, Pierre, Cerroni, Lorenzo, DeLeval, Laurence, Dirnhoffer, Stefan, Dogan, Ahmet, Feldman, Andrew L, Fend, Falko, Friedberg, Jonathan W, Gaulard, Philippe, Ghia, Paolo, Horwitz, Steven M, King, Rebecca L, Salles, Gilles, San-Miguel, Jesus, Seymour, John F, Treon, Steven P, Vose, Julie M, Zucca, Emanuele, Advani, Ranjana, Ansell, Stephen, Au, Wing-Yan, Barrionuevo, Carlos, Bergsagel, Leif, Chan, Wing C., Cohen, Jeffrey I, d’Amore, Francesco, Davies, Andrew, Falini, Brunangelo, Ghobrial, Irene M, Goodlad, John, Gribben, John G, Hsi, Eric D, Kahl, Brad S, Kim, Won-Seog, Kumar, Shaji, LaCasce, Ann S, Laurent, Camille, Lenz, George, Leonard, John P, Link, Michael P, Lopez-Guillermo, Armando, Manteca, Maria Victoria Mateos, Macintyre, Elizabeth, Melnick, Ari M, Morschhauser, Franck, Nakamura, Shigeo, Narbaitz, Marina, Paulovsky, Astrid, Pileri, Stefano A, Piris, Miguel, Pro, Barbara, Rajkumar, Vincent, Rosen, Steven T, Sander, Birgitta, Sehn, Laurie, Shipp, Margaret A, Smith, Sonali M, Staudt, Louis M, Thieblemont, Catherine, Tousseyn, Thomas, Wilson, Wyndham H, Yoshino, Tadashi, Zinzani, Pier-Luigi, Dreyling, Martin, Scott, David W, Winter, Jane N, Zelenetz, Andrew D

Volltext

Current and Novel Approaches in DLBCL von Salles, Gilles A.

Volltext

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma von Morschhauser, Franck, Fowler, Nathan H, Feugier, Pierre, Bouabdallah, Reda, Tilly, Hervé, Palomba, M. Lia, Fruchart, Christophe, Libby, Edward N, Casasnovas, Rene-Olivier, Flinn, Ian W, Haioun, Corinne, Maisonneuve, Hervé, Ysebaert, Loic, Bartlett, Nancy L, Bouabdallah, Kamal, Brice, Pauline, Ribrag, Vincent, Daguindau, Nicolas, Le Gouill, Steven, Pica, Gian M, Martin Garcia-Sancho, Alejandro, López-Guillermo, Armando, Larouche, Jean-François, Ando, Kiyoshi, Gomes da Silva, Maria, André, Marc, Zachée, Pierre, Sehn, Laurie H, Tobinai, Kensei, Cartron, Guillaume, Liu, David, Wang, Jianming, Xerri, Luc, Salles, Gilles A

Volltext

Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial von Jacobson, Caron A, Chavez, Julio C, Sehgal, Alison R, William, Basem M, Munoz, Javier, Salles, Gilles, Munshi, Pashna N, Casulo, Carla, Maloney, David G, de Vos, Sven, Reshef, Ran, Leslie, Lori A, Yakoub-Agha, Ibrahim, Oluwole, Olalekan O, Fung, Henry Chi Hang, Rosenblatt, Joseph, Rossi, John M, Goyal, Lovely, Plaks, Vicki, Yang, Yin, Vezan, Remus, Avanzi, Mauro P, Neelapu, Sattva S

Volltext

Obinutuzumab (GA101) Monotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Mantle-Cell Lymphoma: Results From the Phase II GAUGUIN Study von Morschhauser, Franck Andre, Cartron, Guillaume, Thieblemont, Catherine, Solal-Céligny, Philippe, Haioun, Corinne, Bouabdallah, Reda, Feugier, Pierre, Bouabdallah, Krimo, Asikanius, Elina, Lei, Guiyuan, Wenger, Michael, Wassner-Fritsch, Elisabeth, Salles, Gilles Andre

Volltext

PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma von Gopal, Ajay K, Kahl, Brad S, de Vos, Sven, Wagner-Johnston, Nina D, Schuster, Stephen J, Jurczak, Wojciech J, Flinn, Ian W, Flowers, Christopher R, Martin, Peter, Viardot, Andreas, Blum, Kristie A, Goy, Andre H, Davies, Andrew J, Zinzani, Pier Luigi, Dreyling, Martin, Johnson, Dave, Miller, Langdon L, Holes, Leanne, Li, Daniel, Dansey, Roger D, Godfrey, Wayne R, Salles, Gilles A

Volltext

Obinutuzumab (GA101) in Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: Results From the Phase II GAUGUIN Study von Salles, Gilles A, Morschhauser, Franck, Solal-Céligny, Philippe, Thieblemont, Catherine, Lamy, Thierry, Tilly, Hervé, Gyan, Emmanuel, Lei, Guiyuan, Wenger, Michael, Wassner-Fritsch, Elisabeth, Cartron, Guillaume

Volltext

Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies von Meignan, Michel, Cottereau, Anne Ségolène, Versari, Annibale, Chartier, Loïc, Dupuis, Jehan, Boussetta, Sami, Grassi, Ilaria, Casasnovas, René-Olivier, Haioun, Corinne, Tilly, Hervé, Tarantino, Vittoria, Dubreuil, Julien, Federico, Massimo, Salles, Gilles, Luminari, Stefano, Trotman, Judith

Volltext